These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

240 related articles for article (PubMed ID: 14578310)

  • 1. Report of the National Heart, Lung, and Blood Institute Workshop on Lipoprotein(a) and Cardiovascular Disease: recent advances and future directions.
    Marcovina SM; Koschinsky ML; Albers JJ; Skarlatos S
    Clin Chem; 2003 Nov; 49(11):1785-96. PubMed ID: 14578310
    [TBL] [Abstract][Full Text] [Related]  

  • 2. NHLBI Working Group Recommendations to Reduce Lipoprotein(a)-Mediated Risk of Cardiovascular Disease and Aortic Stenosis.
    Tsimikas S; Fazio S; Ferdinand KC; Ginsberg HN; Koschinsky ML; Marcovina SM; Moriarty PM; Rader DJ; Remaley AT; Reyes-Soffer G; Santos RD; Thanassoulis G; Witztum JL; Danthi S; Olive M; Liu L
    J Am Coll Cardiol; 2018 Jan; 71(2):177-192. PubMed ID: 29325642
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Lipoprotein(a): A Genetically Determined, Causal, and Prevalent Risk Factor for Atherosclerotic Cardiovascular Disease: A Scientific Statement From the American Heart Association.
    Reyes-Soffer G; Ginsberg HN; Berglund L; Duell PB; Heffron SP; Kamstrup PR; Lloyd-Jones DM; Marcovina SM; Yeang C; Koschinsky ML;
    Arterioscler Thromb Vasc Biol; 2022 Jan; 42(1):e48-e60. PubMed ID: 34647487
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Use of a reference material proposed by the International Federation of Clinical Chemistry and Laboratory Medicine to evaluate analytical methods for the determination of plasma lipoprotein(a).
    Marcovina SM; Albers JJ; Scanu AM; Kennedy H; Giaculli F; Berg K; Couderc R; Dati F; Rifai N; Sakurabayashi I; Tate JR; Steinmetz A
    Clin Chem; 2000 Dec; 46(12):1956-67. PubMed ID: 11106328
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Lipoprotein(a) and apolipoprotein(a) isoform size: Associations with angiographic extent and severity of coronary artery disease, and carotid artery plaque.
    Ooi EM; Ellis KL; Barrett PHR; Watts GF; Hung J; Beilby JP; Thompson PL; Stobie P; McQuillan BM
    Atherosclerosis; 2018 Aug; 275():232-238. PubMed ID: 29960898
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Lipoprotein(a)-cholesterol and coronary heart disease in the Framingham Heart Study.
    Seman LJ; DeLuca C; Jenner JL; Cupples LA; McNamara JR; Wilson PW; Castelli WP; Ordovas JM; Schaefer EJ
    Clin Chem; 1999 Jul; 45(7):1039-46. PubMed ID: 10388480
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Lipoprotein(a) screening in patients with controlled traditional risk factors undergoing percutaneous coronary intervention.
    Weiss MC; Berger JS; Gianos E; Fisher E; Schwartzbard A; Underberg J; Weintraub H
    J Clin Lipidol; 2017; 11(5):1177-1180. PubMed ID: 28801030
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Elevated lipoprotein(a) and low-density lipoprotein cholesterol as predictors of the severity and complexity of angiographic lesions in patients with premature coronary artery disease.
    Chieng D; Pang J; Ellis KL; Hillis GS; Watts GF; Schultz CJ
    J Clin Lipidol; 2018; 12(4):1019-1026. PubMed ID: 29703625
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Lipoprotein(a): more interesting than ever after 50 years.
    Dubé JB; Boffa MB; Hegele RA; Koschinsky ML
    Curr Opin Lipidol; 2012 Apr; 23(2):133-40. PubMed ID: 22327610
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Future Directions to Establish Lipoprotein(a) as a Treatment for Atherosclerotic Cardiovascular Disease.
    Stein EA; Raal F
    Cardiovasc Drugs Ther; 2016 Feb; 30(1):101-8. PubMed ID: 26861250
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Lipoprotein(a) as a risk factor for coronary artery disease.
    Marcovina SM; Koschinsky ML
    Am J Cardiol; 1998 Dec; 82(12A):57U-66U; discussion 86U. PubMed ID: 9915664
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prevention of cardiovascular complications in patients with Lp(a)-hyperlipoproteinemia and progressive cardiovascular disease by long-term lipoprotein apheresis according to German national guidelines.
    Klingel R; Heibges A; Fassbender C;
    Clin Res Cardiol Suppl; 2017 Mar; 12(Suppl 1):38-43. PubMed ID: 28185214
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Screening and therapeutic management of lipoprotein(a) excess: review of the epidemiological evidence, guidelines and recommendations.
    Lippi G; Franchini M; Targher G
    Clin Chim Acta; 2011 May; 412(11-12):797-801. PubMed ID: 21256836
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Lipoprotein(a) interactions with lipid and non-lipid risk factors in patients with early onset coronary artery disease: results from the NHLBI Family Heart Study.
    Hopkins PN; Hunt SC; Schreiner PJ; Eckfeldt JH; Borecki IB; Ellison CR; Williams RR; Siegmund KD
    Atherosclerosis; 1998 Dec; 141(2):333-45. PubMed ID: 9862182
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Lipoprotein (a), a cardiovascular risk factor: importance of its determination in current clinical practice].
    Couderc R; Maachi M
    J Mal Vasc; 1998 Jun; 23(3):165-75. PubMed ID: 9669219
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Lipoprotein(a) as a cardiovascular risk factor].
    van Lennep JE; Mulder MT
    Ned Tijdschr Geneeskd; 2011; 155(42):A3582. PubMed ID: 22027461
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [The smoking gun of cardiovascular diseases? The great interest in Lp(a)-lipoprotein].
    Dahlén GH
    Lakartidningen; 1993 Jan; 90(4):259-62. PubMed ID: 8433604
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [New data about lipoprotein(a): a curious molecule or a causal cardiovascular risk factor?].
    de Brouckère V; Liénart F; Ducobu J
    Rev Med Brux; 2010; 31(3):171-6. PubMed ID: 20687444
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Lipoprotein(a): a causal independent risk factor for coronary heart disease?
    Gudnason V
    Curr Opin Cardiol; 2009 Sep; 24(5):490-5. PubMed ID: 19623058
    [TBL] [Abstract][Full Text] [Related]  

  • 20. To test, or not to test: that is the question for the future of lipoprotein(a).
    Ellis KL; Chakraborty A; Moses EK; Watts GF
    Expert Rev Cardiovasc Ther; 2019 Apr; 17(4):241-250. PubMed ID: 30916582
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.